Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

European Journal of Cancer(2025)10.1016/j.ejca.2025.115589Source: DataRank Database

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023) is a research paper published in European Journal of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 7.81)OA: hybridTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Charalampos S. Floudas ORCID,Marco Filetti ORCID,Tommaso Giovagnoli,Stefano Sganga ORCID,Antonio Vitale ORCID

Live enrichment

PubMed:40602341 PMC:PMC12359999 OpenAlex:https://openalex.org/W4411682677

Intramural NIH HHS

Grant: Z99 CA999999

FWCI

7.81

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://www.ejcancer.com/action/showPdf?pii=S0959804925003715

publisherhttps://www.ejcancer.com/action/showPdf?pii=S0959804925003715

publisherhttps://api.elsevier.com/content/article/PII:S0959804925003715?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804925003715?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejca.2025.115589

Fields of Study

Ethics in Clinical ResearchCancer Genomics and DiagnosticsEconomic and Financial Impacts of Cancer

MeSH Terms

Antineoplastic AgentsClinical Trials as TopicCross-Sectional StudiesEligibility DeterminationFemaleHumansMaleNeoplasmsUnited StatesUnited States Food and Drug AdministrationDrug ApprovalPatient Selection

Keywords

MedicineInterquartile rangeClinical trialGeneralizability theoryInternal medicineFood and drug administrationConfidence intervalCancerClinical OncologyPerformance statusOncologyPharmacologySolid tumorEligibility Criteria

Sustainable Development Goals

SDG 0: Zero hunger